<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Global X Artificial Intelligence & Technology Etf — News on 6ix</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf</link>
<description>Latest news and press releases for Global X Artificial Intelligence & Technology Etf on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/global-x-artificial-intelligence-and-technology-etf" rel="self" type="application/rss+xml" />
<item>
<title>Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-15</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-15</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University</description>
</item>
<item>
<title>Forward Air Named to Newsweek’s List of Most Trustworthy Companies in America 2026</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/forward-air-named-to-newsweeks-list-of-most-trustworthy-companies-in-america-2026-7</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/forward-air-named-to-newsweeks-list-of-most-trustworthy-companies-in-america-2026-7</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS--(BUSINESS WIRE)-- Forward Air Corporation (NASDAQ: FWRD) (“Forward” or the “Company”) today announced it has been named to Newsweek’s list of the</description>
</item>
<item>
<title>Willow Lane Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 6, 2026</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/willow-lane-acquisition-corp-ii-announces-the-separate-trading-of-its-class-a-ordinary-shares-and-warrants-commencing-april-6-2026-2</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/willow-lane-acquisition-corp-ii-announces-the-separate-trading-of-its-class-a-ordinary-shares-and-warrants-commencing-april-6-2026-2</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>NEW YORK, April 2, 2026 /PRNewswire/ -- Willow Lane Acquisition Corp. II (the "Company") announced today that, commencing April 6, 2026, holders of the units</description>
</item>
<item>
<title>Carpenter Technology Announces Conference Call and Webcast</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/carpenter-technology-announces-conference-call-and-webcast-12</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/carpenter-technology-announces-conference-call-and-webcast-12</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Wednesday, April</description>
</item>
<item>
<title>Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-7</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-7</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close</description>
</item>
<item>
<title>Rivian Releases Q1 2026 Production and Delivery Figures and Sets Date for First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/rivian-releases-q1-2026-production-and-delivery-figures-and-sets-date-for-first-quarter-2026-financial-results-7</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/rivian-releases-q1-2026-production-and-delivery-figures-and-sets-date-for-first-quarter-2026-financial-results-7</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>IRVINE, Calif.--(BUSINESS WIRE)-- Rivian Automotive, Inc. (NASDAQ: RIVN) today announced production and delivery totals for the quarter ending March 31,</description>
</item>
<item>
<title>Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-16</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-16</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k)</description>
</item>
<item>
<title>TransGlobal Assets Inc. (OTCID: TMSH) Provides Strategic Update on M Love Vintage and Appoints Industry Veteran Christopher A. Villareale as President</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/transglobal-assets-inc-otcid-tmsh-provides-strategic-update-on-m-love-vintage-and-appoints-industry-veteran-christopher-a-villareale-as-president-1</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/transglobal-assets-inc-otcid-tmsh-provides-strategic-update-on-m-love-vintage-and-appoints-industry-veteran-christopher-a-villareale-as-president-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>CHEYENNE, Wyo., April 02, 2026 (GLOBE NEWSWIRE) -- Following the previously announced acquisition of M Love Vintage Holdings, Inc. on February 26, 2026,</description>
</item>
<item>
<title>LandBridge Announces Agreement with PowerBridge for the Development of a 2 GW Powered Data Center Campus</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/landbridge-announces-agreement-with-powerbridge-for-the-development-of-a-2-gw-powered-data-center-campus-5</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/landbridge-announces-agreement-with-powerbridge-for-the-development-of-a-2-gw-powered-data-center-campus-5</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Agreement provides option to lease acreage for the development of a 2 GW powered data center campus in West Texas on LandBridge acreage in close proximity to</description>
</item>
<item>
<title>Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/caris-life-sciences-announces-launch-of-caris-chromoseq-the-worlds-first-whole-genome-and-whole-transcriptome-tumor-profiling-assay-for-myeloid-malignancies-3</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/caris-life-sciences-announces-launch-of-caris-chromoseq-the-worlds-first-whole-genome-and-whole-transcriptome-tumor-profiling-assay-for-myeloid-malignancies-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Ultra-deep Whole Genome and Transcriptome Sequencing provides a more complete workup for myeloid malignancies with clearer, faster diagnostic insightIRVING,</description>
</item>
<item>
<title>Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-10</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-10</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix recently Entered into a</description>
</item>
<item>
<title>Plato Gold Corp. Announces Sale of Timmins-Area Properties to Mayfair Gold Corp.</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-10</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-10</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>TORONTO, Ontario, April 02, 2026 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”)</description>
</item>
<item>
<title>QT Imaging CEO Discusses the Importance of Early Breast Cancer Detection at the Shiftmakers’ Panel and Gala</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/qt-imaging-ceo-discusses-the-importance-of-early-breast-cancer-detection-at-the-shiftmakers-panel-and-gala-5</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/qt-imaging-ceo-discusses-the-importance-of-early-breast-cancer-detection-at-the-shiftmakers-panel-and-gala-5</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>NOVATO, Calif.--(BUSINESS WIRE)-- QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming</description>
</item>
<item>
<title>SurgePays Launches Stored Value and Loyalty Platform Across Retail Network</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/surgepays-launches-stored-value-and-loyalty-platform-across-retail-network-9</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/surgepays-launches-stored-value-and-loyalty-platform-across-retail-network-9</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New Platform Capabilities Designed to Increase Revenue Per Store and Further Integrate SurgePays into Core Merchant Operations BARTLETT, Tenn., April 02, 2026</description>
</item>
<item>
<title>Mama’s Creations Appoints Fred Halvin to Board of Directors</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/mamas-creations-appoints-fred-halvin-to-board-of-directors-1</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/mamas-creations-appoints-fred-halvin-to-board-of-directors-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Veteran Corporate Development Executive Brings 37 Years of M&A, Strategic Growth and Food Industry Experience at Hormel Foods to the Board EAST RUTHERFORD,</description>
</item>
<item>
<title>Advisory: Chevron Corporation’s 1Q 2026 Earnings Conference Call and Webcast</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/advisory-chevron-corporations-1q-2026-earnings-conference-call-and-webcast-6</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/advisory-chevron-corporations-1q-2026-earnings-conference-call-and-webcast-6</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>HOUSTON--(BUSINESS WIRE)-- Chevron Corporation (NYSE: CVX), one of the world's leading energy companies, will hold its quarterly earnings conference call on</description>
</item>
<item>
<title>Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/entera-bio-announces-pricing-of-dollar100-million-direct-investment-by-bvf-partners-with-potential-for-up-to-dollar245-million-in-total-proceeds-1</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/entera-bio-announces-pricing-of-dollar100-million-direct-investment-by-bvf-partners-with-potential-for-up-to-dollar245-million-in-total-proceeds-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides,</description>
</item>
<item>
<title>Innovative Aerosystems Acquires Autopilot, Nav/Com, Display and Transponder Solutions from Honeywell, Further Strengthening Integrated Cockpit Avionics Platform</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/innovative-aerosystems-acquires-autopilot-navcom-display-and-transponder-solutions-from-honeywell-further-strengthening-integrated-cockpit-avionics-platform</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/innovative-aerosystems-acquires-autopilot-navcom-display-and-transponder-solutions-from-honeywell-further-strengthening-integrated-cockpit-avionics-platform</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>EXTON, Pa.--(BUSINESS WIRE)-- Innovative Aerosystems (Nasdaq: ISSC), a U.S.-based company specializing in the engineering, manufacturing, and supply of</description>
</item>
<item>
<title>SM ENERGY ANNOUNCES EXPIRATION AND FINAL TENDER RESULTS OF PREVIOUSLY ANNOUNCED CASH TENDER OFFER</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/sm-energy-announces-expiration-and-final-tender-results-of-previously-announced-cash-tender-offer-2</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/sm-energy-announces-expiration-and-final-tender-results-of-previously-announced-cash-tender-offer-2</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DENVER, April 2, 2026 /PRNewswire/ -- SM Energy Company ("SM Energy") (NYSE: SM) today announced the final tender results of the previously announced cash</description>
</item>
<item>
<title>Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform</title>
<link>https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/oncotelic-therapeutics-announces-strategic-partnership-with-techforce-robotics-to-commercialize-pdaoai-enhanced-gmp-robotics-platform-8</link>
<guid isPermaLink="true">https://6ix.com/company/global-x-artificial-intelligence-and-technology-etf/news/oncotelic-therapeutics-announces-strategic-partnership-with-techforce-robotics-to-commercialize-pdaoai-enhanced-gmp-robotics-platform-8</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biotechnology company</description>
</item>
</channel>
</rss>